HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Schmitt Selected Research

HER2p63 peptide

5/2002Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Schmitt Research Topics

Disease

48Neoplasms (Cancer)
05/2022 - 05/2002
38Leukemia
02/2019 - 09/2002
22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 07/2003
12Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 08/2005
9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 06/2008
9Multiple Myeloma
10/2020 - 02/2008
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 10/2006
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2008 - 09/2002
7Infections
10/2021 - 11/2004
6Inflammation (Inflammations)
12/2021 - 06/2010
6Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2021 - 01/2014
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2020
5Lymphoma (Lymphomas)
10/2021 - 04/2009
4Carcinoma (Carcinomatosis)
12/2021 - 09/2002
4Residual Neoplasm
04/2016 - 12/2006
4Squamous Cell Carcinoma of Head and Neck
07/2013 - 05/2005
4Melanoma (Melanoma, Malignant)
05/2013 - 09/2002
3Testicular Neoplasms (Testicular Cancer)
02/2022 - 01/2007
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2021 - 10/2016
3Neoplasm Metastasis (Metastasis)
07/2020 - 09/2002
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2016 - 02/2008
2COVID-19
02/2022 - 10/2020
2Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 02/2021
2Communicable Diseases (Infectious Diseases)
10/2021 - 11/2004
2Necrosis
10/2021 - 01/2009
2Cytomegalovirus Infections (Inclusion Disease)
10/2020 - 04/2011
2Arthritis (Polyarthritis)
06/2010 - 11/2004
2Renal Cell Carcinoma (Grawitz Tumor)
06/2004 - 09/2002
2Breast Neoplasms (Breast Cancer)
08/2003 - 09/2002
1Wilms Tumor (Wilm's Tumor)
12/2022
1Sarcoma (Soft Tissue Sarcoma)
02/2022
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2022
1cell-associated neurotoxicity
01/2022
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Cytokine Release Syndrome
01/2022
1T-Cell Leukemia (Leukemia, T Cell)
12/2021
1Burkitt Lymphoma (Burkitt's Lymphoma)
12/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2021
1Encephalitis (Encephalitis, Rasmussen)
10/2021
1Amyloidosis
01/2021

Drug/Important Bio-Agent (IBA)

41AntigensIBA
02/2022 - 09/2002
25Chimeric Antigen ReceptorsIBA
05/2022 - 10/2016
18Peptides (Polypeptides)IBA
01/2022 - 05/2002
11Proteins (Proteins, Gene)FDA Link
10/2021 - 05/2002
8Hyaluronic Acid (Hyaluronan)IBA
03/2009 - 09/2002
6VaccinesIBA
01/2021 - 08/2005
5Messenger RNA (mRNA)IBA
01/2019 - 09/2002
5CytokinesIBA
01/2019 - 09/2007
5EnzymesIBA
06/2018 - 08/2005
4SteroidsIBA
01/2022 - 03/2015
4ProdrugsIBA
12/2021 - 01/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2019
4Protein Subunit VaccinesIBA
01/2021 - 04/2009
4Cancer VaccinesIBA
01/2016 - 12/2005
4Imatinib Mesylate (Gleevec)FDA Link
06/2008 - 12/2006
3Retinaldehyde (Retinal)IBA
01/2022 - 10/2018
3Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2007
3AntibodiesIBA
10/2020 - 08/2003
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
04/2016 - 08/2005
3Viral AntigensIBA
02/2010 - 09/2008
3Granzymes (Granzyme)IBA
06/2007 - 04/2006
2axicabtagene ciloleucelIBA
05/2022 - 10/2021
2LipidsIBA
12/2021 - 09/2017
2Antiviral Agents (Antivirals)IBA
01/2019 - 01/2018
2NucleophosminIBA
12/2017 - 08/2012
2Combined VaccinesIBA
01/2011 - 02/2004
2Complementary DNA (cDNA)IBA
09/2009 - 02/2007
2Neoplasm Antigens (Tumor Antigens)IBA
03/2009 - 02/2007
2ImmunosorbentsIBA
03/2009 - 04/2006
2Dasatinib (BMS 354825)FDA Link
01/2009 - 10/2008
2FibromodulinIBA
09/2008 - 10/2006
2EpitopesIBA
09/2008 - 08/2005
2SurvivinIBA
09/2008 - 10/2006
2AcidsIBA
09/2007 - 09/2002
2catumaxomabIBA
09/2007 - 05/2005
2Epithelial Cell Adhesion MoleculeIBA
09/2007 - 05/2005
1WT1 ProteinsIBA
12/2022
1tisagenlecleucelIBA
05/2022
1Histone Deacetylase InhibitorsIBA
02/2022
1PhosphoproteinsIBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Gemtuzumab (Mylotarg)FDA Link
01/2022
1Peroxidase (Myeloperoxidase)IBA
12/2021
1Antifungal AgentsIBA
10/2021
1sinapigladiosideIBA
10/2021
1toxoflavinIBA
10/2021
1Biological ProductsIBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Extracellular Matrix ProteinsIBA
01/2021
1ibrutinibIBA
01/2021

Therapy/Procedure

32Immunotherapy
02/2022 - 09/2002
24Stem Cell Transplantation
02/2022 - 07/2003
21Therapeutics
04/2021 - 09/2002
11Drug Therapy (Chemotherapy)
01/2020 - 07/2003
5Hematopoietic Stem Cell Transplantation
01/2020 - 12/2006
4Photopheresis
01/2022 - 03/2015
4Cell Transplantation
01/2022 - 10/2020
2Kidney Transplantation
01/2022 - 02/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2022